Appaloosa LP’s Bausch Health BHC Stock Holding History

Appaloosa LP’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-945,000	Closed	-$24.9M	–	40
2016 Q1	$24.9M	Buy	+945,000	New	+$69.9M	0.44%	39

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Appaloosa LP's BHC Position: Q2 2016 in Review

Appaloosa LP sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 945,000 shares — an estimated $24.9M sold.

Appaloosa LP first reported a position in BHC in Q1 2016 and held it in 1 quarter. The position peaked at $24.9M in Q1 2016. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

Appaloosa LP reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
Appaloosa LP sold 945,000 Bausch Health shares in Q2 2016, an estimated $24.9M.
Appaloosa LP first reported a position in Bausch Health in Q1 2016 and held it in 1 quarter.
Appaloosa LP's Bausch Health position peaked at $24.9M in Q1 2016.
347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Appaloosa LP's 13F filing for Q2 2016, filed 12 Aug 2016.